Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations

Table 1

Personal and family history of cancer in BRCA1 and BRCA2 mutation carriers.

Patients with available history,	Cancer type	Personal history, (%)	Familial history, (%)
BRCA1	Breast	16 (51.6)	28 (90.3)
	Colon	1 (3.2)	4 (12.9)
	Esophageal	0	1 (3.2)
	Gastric	0	1 (3.2)
	Leukemia	0	1 (3.2)
	Lung	0	4 (12.9)
	Melanoma	0	1 (3.2)
	Ovarian	2 (6.5)	14 (45.2)
	Pancreatic	1 (3.2)	0
	Prostate	0	4 (12.9)
	Renal	0	0
Patients with available history,	Cancer type	Personal history, (%)	Familial history, (%)
BRCA2	Breast	6 (24.0)	22 (88.0)
	Colon	0	6 (24.0)
	Esophageal	0	0
	Gastric	0	2 (8.0)
	Leukemia	0	0
	Lung	0	2 (8.0)
	Melanoma	0	1 (4.0)
	Ovarian	2 (8.0)	12 (48.0)
	Pancreatic	1 (4.0)	4 (16.0)
	Prostate	0	2 (8.0)
	Renal	0	2 (8.0)